openPR Logo
Press release

What Factors are Affecting Growth and Demand of Atopic Dermatitis Market | Trends and Forecast till 2027 by Fact.MR

06-17-2021 02:35 AM CET | Health & Medicine

Press release from: Fact.MR

Dermatological disorders are increasing with each passing day. The World Health Organization estimates that more than 900 million people are suffering from skin ailments since 2017.

Click here to Get Complete Synopsis of the Report – https://www.factmr.com/report/4603/atopic-dermatitis-market

Atopic dermatitis accounts for a major chunk of these illnesses, with more than 300 million people, mostly children, affected by it. Based on the aforementioned trends, the global atopic dermatitis drugs is expected to register astounding growth of 24% between 2020 and 2027.

Research and development in manufacturing novel drugs, rising demand for biologics and product approvals are other factors augmenting market growth. On this premise, the atopic dermatitis market is poised to surpass a valuation of US$ 19 Bn by the end of the forecast period.

For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4603

Key Takeaways of Global Atopic Dermatitis Drugs Market Study

• Biologics Drugs is the leading segment by drug class. Projected CAGR for the same is pegged at a staggering CAGR of 32.1% during the forecast period. New product launches and increased adoption of Biologics drugs are key factors driving the growth of the segment.
• PDE4 Inhibitors closely follow the biologics drugs segment, registering a whopping CAGR of 31.1%. Increased affordability of treatment and intensive research and development are expected to drive the growth of PDE4 Inhibitors.
• Retail Pharmacies are expected to account for three-fourth of the market share for atopic dermatitis drugs. Increased number of retail pharmacies, easy availability of therapeutic drugs and convenience are some contributing factors.

For critical insights on this market, request for methodology here - https://www.factmr.com/connectus/sample?flag=RM&rep_id=4603

• North America shall retain its dominance in the atopic dermatitis drugs market. Adoption of advanced biologics drugs, adequate reimbursement coverage for pharmaceutical companies and greater market penetration of new players are some major growth stimulators. The region is set to expand at a CAGR of 27% during the forecast period.
• Europe is the second most attractive market, accounting for around one-third of the global atopic dermatitis drugs market. This is due to increased awareness about the disease, favorable medical reimbursement policies and well-established healthcare facilities.

For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4603

Global Atopic Dermatitis Drugs Market Segmentation

Fact.MR has studied the global atopic dermatitis drugs market with detailed segmentation on the basis product type, application and key regions.

Drug Class
• Corticosteroids
• PDE4 Inhibitors
• Biologics
• Skin Barrier Emollients
• CNI Immunosuppressants
• Others

Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Key Regions
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/05/30/1859437/0/en/MRI-Guided-Radiation-Therapy-Systems-Touted-as-Future-of-Cancer-Treatment-finds-Fact-MR-study.html

Development of Novel Drugs to Determine Market Competitiveness

Investments in development of novel pipeline drugs is expected to shape the global atopic dermatitis drugs market competitiveness. An example for this is the development of the biologics drug DUPIXNET ® by Sanofi Genzyme, which cures skin lesions and reduces itching. It does so by inhibiting secretions of interleukin-4 (IL-4) and interleukin-13 (IL-13) protein strains, responsible for type 2 skin inflammation. Likewise, Eucrisa (crisaborole), developed by Pfizer, Inc., consists of PDE4 Inhibitors to treat skin ailments like Eczema. It works by controlling the over-reactive parts of the PDE4 enzyme within skin cells to prevent inflammation.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1373/global-atopic-dermatitis-market

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What Factors are Affecting Growth and Demand of Atopic Dermatitis Market | Trends and Forecast till 2027 by Fact.MR here

News-ID: 2307174 • Views: 353

More Releases from Fact.MR

Demand for Office Chair Market to Grow at a 5.6% value CAGR Through 2028
Office chair market prospects are likely to be significantly influenced by surging number of startups. Influx of entrepreneurs in developed and emerging markets has created the requirement for tech parks as well as office spaces, which in turn has favored growth of the office chair market in recent years. In terms of value, the office chair market size was estimated at nearly US$ 7330 Mn in 2017 by a recently
07-30-2021 | Sports
Fact.MR
Pole Vault Equipment Market: Soaring Demand Assures Motivated Revenue Share by 2 …
The pole vault equipment market has been witnessing a considerable shift from conventional distribution channel towards direct to customer sales channel, given its benefit of building strong relationship between manufacturers and customers with respect to brand image. Moreover, direct to customer sales channel allows companies to gain customer data that can be used to enhance business development and build long term relationship with customers. For detailed insights on enhancing your product
Revenues from Installation & Construction Data Centers to Exceed US$ 145,000 Mn …
As data centers shift toward supporting more digital strategies, their business will depend on the capabilities of the IT ecosystem to underpin new initiatives. The requirement for a more decentralized approach, to address the need for digital business infrastructure, has been recognized by organizations that have embarked on the digital business journey. For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=920 A new Fact.MR study
Worldwide 1,088,690,000 Tons of Starchy Roots Market to be Sold by 2028-end
Starchy roots market continues to witness steady traction as various types of tuber and root crops such as sweet potato, cassava, potato and yam are one of the important foods in the sub-tropical and tropical regions across the globe. For detailed insights on enhancing your product footprint, request for a sample here - https://www.factmr.com/connectus/sample?flag=S&rep_id=919   Given the varying contribution of starchy roots apropos of energy supply impacted by different consumption requirements across

All 5 Releases


More Releases for PDE4

02-01-2021 | Health & Medicine
Fact.MR
North America shall retain its dominance in the Atopic Dermatitis Drugs Market w …
Dermatological disorders are increasing with each passing day. The World Health Organization estimates that more than 900 million people are suffering from skin ailments since 2017. Atopic dermatitis accounts for a major chunk of these illnesses, with more than 300 million people, mostly children, affected by it. Based on the aforementioned trends, the global atopic dermatitis drugs is expected to register astounding growth of 24% between 2020 and 2027. Research and
Biologics Drugs and PDE4 Inhibitors Account for Major Chunk of Atopic Dermatitis …
Global atopic dermatitis market is poised for astounding growth at approximately 24.1% CAGR during the projection period (2020-2027). Millions of people continue to be affected by debilitating skin ailments which in turn escalates the development of new pharmaceutical drugs. Fact.MR projects the revenue pool of atopic dermatitis market to exceed US$ 19 Bn by 2027 end. “Growing prevalence of dermatological disorders is contributing to the growth of atopic dermatitis market. Manufacturers
Global Psoriatic Arthritis Therapeutics Market : Increasing Demand for Interleuk …
The psoriatic arthritis therapeutics market is poised to display an impressive 11.4% CAGR between 2018 and 2026. Rising prevalence of psoriatic arthritis along with large unmet medical needs are mainly fuelling the psoriatic arthritis therapeutics market. This, coupled with substantial initiatives by product manufacturers to develop novel diagnostic and therapeutic products is likely to translate into notable gains for psoriatic arthritis therapeutics market in the future. Psoriatic Arthritis Therapeutics Market –
Psoriatic Arthritis Therapeutics Market: Efficacy of PDE4 makes it Popular Treat …
The myriad of disease manifestations and the wide range in disease severity and course witnessed in psoriatic arthritis present daunting challenges to the treating clinician. Accordingly, clinicians look to base therapeutic decisions on comprehensive assessments of the different areas of involvement, including nails and the skin. The surge in therapeutic options, namely disease-modifying anti-rheumatic drugs—both biological and targeted synthetic—has elicited clinicians to use the full clinical picture of an individual
Global Psoriatic Arthritis Drugs Market Size, Status by top Key Player and Forec …
A newly compiled business intelligent report, titled “Global Psoriatic Arthritis Drugs Market Size, Status and Forecast 2018-2025” has been publicized to the vast archive of Market Research Hub (MRH) online repository. The study revolves around the analysis of (Psoriatic Arthritis Drugs) market, covering key industry developments and market opportunity map during the mentioned forecast period. This report further conveys quantitative & qualitative analysis on the concerned market, providing a 360
Psoriatic Arthritis Market 2018 focuses on top most players like Janssen Pharmac …
Competitive Insights: The leading players in the market are Janssen Pharmaceutica NV, AbbVie Inc, Pfizer, Bristol-Myers Squibb, Biogen, Sun Pharmaceutical Industries Ltd, Celgene and Eli Lilly And Company. Get Sample Copy of This Report @ https://www.crystalmarketresearch.com/report-sample/HC03620 . The Psoriatic Arthritis Market is segmented as follwos- By Mechanism of Action: Interleukin blockers TNF inhibitors PDE4 inhibitors Others By Type of Disease: Moderate psoriatic arthritis Severe psoriatic arthritis Mild psoriatic arthritis Industry Outlook and Trend Analysis: The Psoriatic Arthritis Market has observed substantial development in the